Maintenance nifedipine therapy for preterm symptomatic placenta previa: A randomized, multicenter, double-blind, placebo-controlled trial
Éric Verspyck(Hôpital Cochin), Jacques Bénichou(National Cancer Institute), Philippe Deruelle(Hôpitaux Universitaires de Strasbourg), Claire de Vienne(Université de Caen Normandie), Michel Dreyfus(Université de Caen Normandie), Isabella Chanavaz‐Lacheray(Université de Rouen Normandie), Michaël Bubenheim(Centre Hospitalier Universitaire de Rouen), Charles Muszynski(Centre Hospitalier Universitaire Amiens-Picardie)
Cited by 17
Related Papers
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection
|JAMA Pediatrics|2021|1.4k
Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
|American Journal of Obstetrics and Gynecology|2021|310
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
|New England Journal of Medicine|2021|272
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
|American Journal of Obstetrics and Gynecology|2020|197
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
|Journal of Internal Medicine|2013|135